MedTrace Logo

Growth and Tolerance of a Partially Hydrolyzed Infant Formula

NCT05047978 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 244

Last updated 2024-01-23

No results posted yet for this study

Summary

The purpose of this research study is to compare the growth and tolerance of infants who consume either an infant formula with intact proteins or an infant formula with partially hydrolyzed proteins through approximately 12 months of age.

Conditions

  • Growth

Interventions

OTHER

Cow's milk protein infant formula

A routine cow's milk-based infant formula

OTHER

Partially hydrolyzed protein infant formula

A partially hydrolyzed cow's milk protein (PHP) infant formula

Sponsors & Collaborators

  • Mead Johnson Nutrition

    lead INDUSTRY

Principal Investigators

  • Steven Wu, Medical Director · Mead Johnson Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
10 Days
Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-28
Primary Completion
2022-10-11
Completion
2023-11-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05047978 on ClinicalTrials.gov